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Compromised development and/or function of CD25 regula-
tory T cells (Tregs) is of central importance for the development 
of autoimmune diseases. The mechanisms that regulate the 
generation of peripheral Tregs are, however, largely unknown. 
To gain insights into Treg differentiation on a molecular level, 
the authors investigated gene expression profi les of Tregs at 
different developmental stages.
Human Tregs were generated in vitro from CD4 CD25-naive 
T cells in the presence of autologous feeder cells and interleu-
kin (IL)4 as described previously by our group. Total RNA was 
isolated at the start and from purifi ed CD25 and CD25 T cells 
at days 3, 5, 7 and 10 of culture and used for DNA microarrays. 
CD25 T cells generated in the absence of IL4 constituted acti-
vated effector T cells (Teffs) lacking regulatory capacity and 
were therefore used to control for Treg-specifi c gene expres-
sion. Differentially expressed transcripts in Tregs and Teffs 
versus CD25 T cells were determined at each time point by the 
microarray data analysis using GeneSpring GX10 software.
A decrease in the number of regulated transcripts was observed 
in Tregs during the development compared with the control 
cell population. Analysis of the biological processes and path-
ways differentially regulated between Tregs and the control 
population revealed an activated and proliferative state of 
Tregs at early developmental stages, progressing to a transcrip-
tionally more quiescent phenotype at later time points. A lack 
of signifi cant overlaps of T cell pathways present in Tregs at 
late development and in Teffs suggests dichotomy of the two 
populations, in particular of mature cells. The transcription 
factor MAFF, the chemokine receptor CCR2, the enzyme pros-
taglandin D synthase and the neuromediator npT1 were iden-
tifi ed as Treg-specifi c genes at different developmental stages. 
Expression of npT1 transcript was most pronounced in mature 
Tregs. Moreover, transcription factors of the FoxO family and 
FoxM1 were identifi ed as molecular pathways specifying Treg 
development and activation of Teffs. These data offer new 
insights into Treg development in the periphery and might 
provide new targets for therapies of disorders caused by dys-
regulation of Tregs.
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